Literature DB >> 14677574

The function of the nuclear receptor peroxisome proliferator-activated receptor delta in energy homeostasis.

George Wolf1.   

Abstract

The metabolic function of the nuclear receptor peroxisome proliferator-activated receptor delta (PPAR(delta)) has been established by transfer of the PPAR(delta) gene into adipose tissue of mice in vivo and into adipocytes in culture. Investigators found that PPAR(delta) activation by such transfer leads to up-regulation of energy expenditure by fatty acid oxidation. PPAR(delta) activation also results in lowered serum triglyceride and free fatty acid levels and decreased lipid accumulation. In vivo activation of PPAR(delta) in adipose tissue protects against obesity and fatty liver in mice fed a high-calorie diet. PPAR(delta) also activates the heat-producing uncoupling enzymes in brown adipose tissue (UCP1 and 3) and muscle (UCP2).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14677574     DOI: 10.1301/nr.2003.nov.387-390

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  5 in total

1.  Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity.

Authors:  Anna Leonardini; Luigi Laviola; Sebastio Perrini; Annalisa Natalicchio; Francesco Giorgino
Journal:  PPAR Res       Date:  2010-02-23       Impact factor: 4.964

2.  A role for phosphodiesterase 3B in acquisition of brown fat characteristics by white adipose tissue in male mice.

Authors:  Emilia Guirguis; Steven Hockman; Youn Wook Chung; Faiyaz Ahmad; Oksana Gavrilova; Nalini Raghavachari; Yanqin Yang; Gang Niu; Xiaoyuan Chen; Zu Xi Yu; Shiwei Liu; Eva Degerman; Vincent Manganiello
Journal:  Endocrinology       Date:  2013-06-13       Impact factor: 4.736

Review 3.  Targeting Energy Expenditure-Drugs for Obesity Treatment.

Authors:  Carlos M Jimenez-Munoz; Marta López; Fernando Albericio; Kamil Makowski
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06

Review 4.  Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.

Authors:  Ryan D Welch; Cyrielle Billon; McKenna Losby; Gonzalo Bedia-Diaz; Yuanying Fang; Amer Avdagic; Bahaa Elgendy; Thomas P Burris; Kristine Griffett
Journal:  Metabolites       Date:  2022-03-11

Review 5.  The role of peroxisome proliferator-activated receptors (PPAR) in immune responses.

Authors:  Anthos Christofides; Eirini Konstantinidou; Chinmay Jani; Vassiliki A Boussiotis
Journal:  Metabolism       Date:  2020-08-11       Impact factor: 8.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.